Proteasome Inhibition in Alzheimer's Disease
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000009
Summary
Although it is clear that increased oxidative damage occurs in AD-affected brains, the mechanism(s) responsible for increasing oxidative stress is still unknown. Dr. Keller has recently found that the formation of a specialized assembly of enzymes known as the multicatalytic proteasome (MCP) is inhibited in AD brains, and that this inhibition leads to oxidative damage and neuron death. Because the MCP is normally involved in breaking down and recycling proteins, it serves important cellular functions. Dr. Keller is focusing on testing the hypothesis that oxidative stress causes inhibition of the MCP, and that MCP inhibition causes the accumulation of oxidized protein and damaged DNA.
Related Grants
Alzheimer's Disease Research
Personalized Proteomics to Understand and Predict Alzheimer’s Progression
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Federica Anastasi, PhD
Current Organization
Barcelonaβeta Brain Research Center
Personalized Proteomics to Understand and Predict Alzheimer’s Progression
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Federica Anastasi, PhD
Current Organization
Barcelonaβeta Brain Research Center
Alzheimer's Disease Research
Neuroimaging and Neuropathology of Alzheimer’s Disease in Down Syndrome
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Jr-Jiun Liou, PhD
Current Organization
University of Pittsburgh
Neuroimaging and Neuropathology of Alzheimer’s Disease in Down Syndrome
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Jr-Jiun Liou, PhD
Current Organization
University of Pittsburgh
Alzheimer's Disease Research
Neurostimulation to Improve Depression and Memory in Dementia
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Davide Cappon, PhD
Current Organization
Hebrew Rehabilitation Center
Neurostimulation to Improve Depression and Memory in Dementia
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Davide Cappon, PhD
Current Organization
Hebrew Rehabilitation Center